Sign in

CIK 0001157601 · Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(267) 824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
  1. 424B2 Offering Prospectus
  2. EFFECT Other Notice of Effectiveness
  3. CT ORDER Other Confidential Order
  4. 4 Open-market buy Director bought 116,997 shares at an average $7.51 ($878,249)
  5. 4 Open-market buy Director bought 26,400 shares at an average $7.16 ($189,050)
  6. S-3 Offering Registration Statement
  7. 10-Q Report Quarterly Report
  8. S-8 Other Securities Offered to Employees in Benefit Plans
  9. 4 Grant or award Sr. VP, Chief Comm. Officer acquired 25,000 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. SC 13D Stake Beneficial Ownership Report
  12. CT ORDER Other Confidential Order
  13. 4 Grant or award Director acquired 1,349 shares (grant or award)
  14. 4 Grant or award Director acquired 5,398 shares (grant or award)
  15. 4 Grant or award Director acquired 5,398 shares (grant or award)
  16. 4 Grant or award Director acquired 8,097 shares (grant or award)
  17. 4 Open-market buy Director bought 30,000 shares at an average $7.16 ($214,874)
  18. 4 Open-market buy Director bought 50,000 shares at an average $7.05 ($352,261)
  19. 10-Q Report Quarterly Report
  20. ARS Other Annual Report to Security Holders

Page 56 of 62 · 1,224 filings